HIV-1 prevention efficacy with emtricitabine plus tenofovir disoproxil fumarate was not significantly different from that of tenofovir disoproxil fumarate alone ( hazard ratio [ HR ] 067 , 95 % CI 039-117 ; p = 016 ) .